Vaccine Queue Netherlands Calculator - RIVM Priority Group

The vaccine queue netherlands calculator is a planning tool that places you in a Dutch COVID-19 priority group and projects weeks to each dose. It assigns you to one of the 10 RIVM groups, sums the population of every group ahead of you, scales by an uptake share, and divides by a chosen weekly dose rate. Pseudo-cohorts 11 and 12 cover pregnancy and under-18, and a Caribbean flag switches to the 3-tier Bonaire, Curaçao, Aruba, and St Maarten framework. The tool is most useful for retrospective analysis of the 2021 to 2022 roll-out.

• • Personal queue position: estimate how many higher-priority people in the Netherlands will be offered the COVID-19 vaccine before you.
• • Caribbean household planning: compare a partner or family member on Bonaire, Curaçao, Aruba, or St Maarten against the Caribbean framework.
• • Rollout what-if analysis: adjust the weekly dose, uptake, or dose gap to see how your first-dose date shifts.
• • RIVM flag screening: confirm whether a healthcare, care home, high-risk, or chronic condition flag moves you into an earlier group.

The Dutch COVID-19 vaccine allocation was structured around the Gezondheidsraad advice of 19 November 2020 and run by the RIVM from 6 January 2021. The 10 mainland groups are sequenced by exposure and clinical risk, from healthcare workers and care home residents through 65+ at home, 60-64, mental health inpatients, 65+ at home not mobile, 18-59 high medical risk, 18-59 chronic conditions, 50-59, and 18-49. The Caribbean islands use a 3-tier framework, while St Eustatius and Saba vaccinated everyone at once.

If you want to compare the Dutch 10-group framework against a single-jurisdiction example, Vaccine Queue Malaysia Calculator places you in the Malaysia PICK phase and projects weeks to each dose using the same queue model.

The calculator is a four-step queue model. It sorts you into a single Dutch priority group (or Caribbean tier), sums the population of every group ahead of you, and divides by the weekly dose rate to estimate weeks to first dose, then adds the dose gap for full vaccination.

• groupPopulation_i: Estimated people in the ith RIVM group, anchored to the CBS mid-2020 resident population of about 17.28 million.
• uptake: Share of each group expected to accept the vaccine. 75% default mirrors the RIVM national intent rate at the start of the broad roll-out.
• weeklyDoses: Assumed weekly doses. 700,000/week equals 100,000 per day in spring 2021.
• doseGapWeeks: Gap between first and second dose, 3 to 12 weeks. Comirnaty 3, Spikevax 4, Vaxzevria 8 to 12.

The group populations are anchored to the Gezondheidsraad advice of 19 November 2020, the RIVM vaccination page, and the CBS mid-2020 resident population of about 17.28 million. Caribbean populations are smaller, so a 55-year-old on Curaçao sees a much shorter queue than a 55-year-old in Amsterdam.

According to RIVM - COVID-19 Vaccination Programme, the Dutch COVID-19 vaccination programme used a ten-group priority framework with healthcare workers in Group 1, nursing home residents in Group 2, 65+ at home in Group 3, 60-64 in Group 4, mental health inpatients in Group 5, 65+ at home not mobile in Group 6, 18-59 high medical risk in Group 7, 18-59 chronic conditions in Group 8, 50-59 in Group 9, and 18-49 in Group 10.

Because the same supply constraint that drives the RIVM weekly dose rate also drives the production rate behind the Dutch queue, Vaccine Production Calculator scales a target population, coverage, and doses per person into total doses needed and a full production timeline.

Four concepts carry the Dutch COVID-19 vaccine allocation model. Understanding each one explains why the calculator places you where it does.

The four concepts are deliberately simple so the calculator can be used at a GGD appointment, in a huisarts waiting room, or in a workplace briefing. Mainland groups are stacked: everyone in Group 1 is invited before Group 2, with the Caribbean framework on a separate track for the Dutch Caribbean islands.

If you would rather measure the epidemiological pressure that justified the Dutch age-and-risk prioritisation, Viral Infection SIR Calculator simulates the spread curve that drove the RIVM priority framework.

Enter the inputs that describe you, then read the assigned Dutch group and the wait estimate. Stress-test the roll-out with the weekly dose, uptake, or dose gap.

1. 1 Enter your age: Type your current age in years (16 to 120). Age 65+ goes to Group 3, 60-64 to Group 4.
2. 2 Set the residency and Caribbean flags: 'Yes' for care home if you live in a nursing or care home, and 'Yes' for Caribbean if you live on Bonaire, Curaçao, Aruba, or St Maarten.
3. 3 Set the personal situation flags: 'Yes' for healthcare worker, mental health inpatient (intramural GGZ), or Group 7 high medical risk (Down syndrome, BMI over 40). 'Yes' for not mobile only if you are 65+ and house-bound. 'Yes' for Group 8 chronic condition (cardiovascular, diabetes, kidney, liver, immune, chronic respiratory).
4. 4 Adjust the roll-out assumptions: Keep the defaults for the spring 2021 estimate, or change the weekly dose, uptake rate, and dose gap.
5. 5 Read the result panel: The panel shows your assigned Dutch group, group description, people ahead, and weeks to each dose.

A 67-year-old in Rotterdam keeps the defaults. The calculator places them in Group 3, sums Groups 1 and 2 at 75% uptake = 510,000, and reports 1 week to first dose and 4 weeks to full vaccination.

If your high-medical-risk flag is driven by body composition, BMI Calculator confirms whether your weight sits in the obesity bracket (BMI over 40) that places an 18-59 adult in RIVM Group 7.

The calculator delivers five practical benefits for people planning around the RIVM roll-out.

• • Group clarity: Translates the RIVM 10-group priority list into a single number for a GGD or huisarts appointment.
• • Queue transparency: Shows the higher-priority populations in front of you, not a vague 'wacht op uw oproep'.
• • What-if flexibility: Lets you model a slower or faster weekly dose rate, a higher or lower uptake, or a 3 to 12 week dose gap.
• • Risk-factor triage: Surfaces whether a healthcare worker, mental health inpatient, house-bound, high medical risk, or chronic condition flag actually moves you into an earlier group.
• • Caribbean comparison: Lets a family member on Bonaire, Curaçao, Aruba, or St Maarten see their framework on the same page.

The biggest practical benefit is reducing the emotional cost of waiting. When you can see that roughly 6.97 million higher-priority people sit in front of you and the roll-out is doing 700,000 doses a week, the wait becomes a number you can plan around. The vaccine queue netherlands calculator also surfaces a screening prompt: people with Down syndrome, a BMI over 40, or a chronic condition often do not realise their condition pulls them forward by an RIVM group.

Five factors drive the calculator's wait estimate, plus two caveats.

• • The model assumes each Dutch group is fully cleared before the next begins. The RIVM ran some overlap in practice, shortening real wait times for groups near the top.
• • Group population figures are estimates, especially for the Group 7 high-risk cohort, where the published list was expanded in February and March 2021.

For a conservative wait estimate, lower the weekly dose to 350,000 and raise uptake to 100%. For an optimistic estimate, raise the weekly dose to 1,500,000.

According to CBS - Netherlands Population, the Netherlands had about 17.28 million residents in mid-2020, of whom roughly 14.13 million were aged 18 and above and therefore in the Dutch adult COVID-19 vaccination programme.

Because chronic kidney disease is one of the Group 8 conditions that pulls an 18-59 adult into the RIVM framework ahead of the 18-49 general adult cohort, GFR Calculator lets you check your estimated glomerular filtration rate before you decide whether to set the chronic-condition flag.